Sitong Du
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Occupational and environmental lung diseases
-
- Immune cells in cancer
Papers in
-
- Galectins and Cancer Biology 2
- Immune Cell Function and Interaction 2
- IL-33, ST2, and ILC Pathways 2
- Macrophage Migration Inhibitory Factor 1
-
- Inflammasome and immune disorders 3
- Co-authors
- Fangwei Liu (6 shared papers)Dong Weng (5 shared papers)Chao Li (6 shared papers)Yiping Lu (6 shared papers)Jie Chen (5 shared papers)Siyi Li (3 shared papers)Ying Chen (4 shared papers)Xue Lei (1 shared paper)
In The Last Decade
Sitong Du
14 papers receiving 542 citations
Peers
Comparison fields: 5 of 78
- Pulmonary and Respiratory Medicine 259
- Immunology 142
- Molecular Medicine 27
- Molecular Biology 216
- Pharmacology 18
Countries citing papers authored by Sitong Du
This map shows the geographic impact of Sitong Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sitong Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sitong Du more than expected).
Fields of papers citing papers by Sitong Du
This network shows the impact of papers produced by Sitong Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sitong Du. The network helps show where Sitong Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Sitong Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 182 | |
| 2 | 2017 | 127 | |
| 3 | 2016 | 47 | |
| 4 | 2013 | 47 | |
| 5 | 2016 | 44 | |
| 6 | 2019 | 19 | |
| 7 | 2011 | 18 | |
| 8 | Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. | 2007 | 15 |
| 9 | 2018 | 14 | |
| 10 | 2014 | 12 | |
| 11 | 2017 | 9 | |
| 12 | 2024 | 6 | |
| 13 | 2015 | 5 | |
| 14 | 2022 | 2 |
About Sitong Du
Sitong Du is a scholar working on Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Genetics, having authored 14 papers that have together received 547 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Inflammasome and immune disorders (3 papers), Occupational and environmental lung diseases (3 papers), Galectins and Cancer Biology (2 papers), Pleural and Pulmonary Diseases (2 papers), Immune Cell Function and Interaction (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Macrophage Migration Inhibitory Factor (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (259 citations), Immunology (142 citations), Molecular Medicine (27 citations), Molecular Biology (216 citations) and Pharmacology (18 citations). Sitong Du has collaborated with scholars based in China, Taiwan and Nepal. Frequent co-authors include Fangwei Liu, Dong Weng, Chao Li, Yiping Lu, Jie Chen, Siyi Li, Ying Chen, Xue Lei, Ying Chen and Xiaowei Lu. Their work appears in journals such as Theranostics, Frontiers in Immunology, Phytomedicine, International Journal of Cancer and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.